KCAS Bioanalytical & Biomarker Services is a full-service global bioanalytical Contract Research Organization (CRO) that offers comprehensive GLP/GCP compliant development services. Specializing in bioanalytical and biomarker services, KCAS Bio supports drug development with a range of services including immunogenicity testing, large and small molecule bioanalysis, flow cytometry, and sample management. With over 40 years of experience, the company has contributed to the support of over 300 FDA-approved drugs and developed more than 5,000 assays. KCAS Bio operates globally, with locations in the US, EU, and strategic alliances in Australia, and is recognized for its innovative approach to maintaining seamless operations and minimizing drug development delays. The company’s expertise spans multiple therapeutic areas including oncology, metabolic, infectious diseases, and neurological conditions.
Immunogenicity (ADA) • Flow Cytometry • Vaccines • Method Dev + Transfer • Clinical PK/PD Kits
November 14
Partnering with clients for bioanalytical services at KCAS.
October 4
Director of Business Development to boost bioanalytical services in EU.